Nerve growth factor therapy for corneal disease

Current Opinion in Ophthalmology, 06/08/2012

Since the first clinical use of topical NGF therapy in patients with neurotrophic keratitis, the ocular surface healing and immune–modulating actions of NGF have been extensively studied and demonstrated in the past two decades, opening new perspectives for its use in clinical practice in patients with infective and noninfective diseases of the ocular surface.

Print Article Summary Cat 2 CME Report